NCT02027259View on ClinicalTrials.gov

Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 19, 2012

Primary Completion Date

October 2, 2015

Study Completion Date

October 2, 2015

Conditions
DiabetesDepression
Interventions
BEHAVIORAL

Behavioral activation (BA)

The addition of Behavioral activation (BA) to our group visits in patients with DM and depression will consist of 4 weekly group visits of 2-hour duration followed by monthly booster group visits for 6 months to prevent relapse.

Trial Locations (1)

02908

Providence VAMC, Providence

All Listed Sponsors
lead

Providence VA Medical Center

FED

NCT02027259 - Behavioral Activation Therapy for Both Depression and Diabetes Vs. Diabetes Alone Delivered Via Group Visits | Biotech Hunter | Biotech Hunter